Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?
Franca Fruzzetti,1 Angelo Cagnacci2 1Department of Obstetrics and Gynaecology, Santa Chiara Hospital, University of Pisa, Pisa, Italy; 2Institute of Obstetrics and Gynecology, Department of Medical Area, University of Udine, Udine, Italy Objective: Estradiol (E2)-based hormonal contraceptives impact...
Saved in:
Main Authors: | Fruzzetti F (Author), Cagnacci A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 and hormonal contraception
by: Angelo Cagnacci, et al.
Published: (2022) -
Contraception with estradiol valerate and dienogest: adherence to the method
by: Fruzzetti F, et al.
Published: (2019) -
Information on the combined hormonal contraceptives (CHC) containing the dienogest + ethinyl estradiol combination (Jeanine®)
by: A. D. Makatsariya, et al.
Published: (2019) -
Personification of hormonal contraception
by: L Yu Karakhalis, et al.
Published: (2016) -
Influence of structured counseling on women's selection of hormonal contraception in Israel: results of the CHOICE study
by: Yeshaya A, et al.
Published: (2014)